Department of Otorhinolaryngology, Eye & ENT Hospital, Fudan University, Shanghai, 200031, China.
Department of Pathology, Eye & ENT Hospital Fudan University, Shanghai, 200031, China.
BMC Cancer. 2022 Sep 26;22(1):1019. doi: 10.1186/s12885-022-10113-5.
To investigate the expression and prognostic value of c-Jun in hypopharyngeal squamous cell carcinoma (HPSCC).
A retrospective study was performed on a cohort of 99 HPSCC patients. The expression of c-Jun and phosphorylated-c-Jun (p-c-Jun) was evaluated via immunohistochemistry (IHC) staining. Overall survival (OS) and progression-free survival (PFS) were assessed using Kaplan-Meier method and multivariate Cox regression analysis.
The high expression of c-Jun and p-c-Jun in HPSCC accounted for 60.61% and 16.16%, respectively. High expression of c-Jun was closely associated with cT stage (p = 0.0401), tumor size (p = 0.0276), number of lymph node metastases (p = 0.0205) and pathological differentiation (p = 0.0108). The expression of c-Jun (p = 0.0043), p-c-Jun (p = 0.0376) and c-Jun/p-c-Jun were closely associated with poor OS. The Cox proportional multivariate hazard model revealed that lymphovascular invasion and c-Jun expression were independent influencing factors of OS in HPSCC patients.
Our findings suggest that c-Jun is a reliable prognostic factors in HPSCC patients.
研究 c-Jun 在下咽鳞癌(HPSCC)中的表达及其预后价值。
对 99 例 HPSCC 患者进行回顾性研究。采用免疫组织化学(IHC)染色法检测 c-Jun 和磷酸化-c-Jun(p-c-Jun)的表达。采用 Kaplan-Meier 法和多因素 Cox 回归分析评估总生存(OS)和无进展生存(PFS)。
HPSCC 中 c-Jun 和 p-c-Jun 的高表达分别占 60.61%和 16.16%。c-Jun 的高表达与 cT 分期(p = 0.0401)、肿瘤大小(p = 0.0276)、淋巴结转移数(p = 0.0205)和病理分化(p = 0.0108)密切相关。c-Jun(p = 0.0043)、p-c-Jun(p = 0.0376)和 c-Jun/p-c-Jun 的表达与 OS 不良密切相关。Cox 比例多因素风险模型显示,血管淋巴管侵犯和 c-Jun 表达是 HPSCC 患者 OS 的独立影响因素。
本研究结果提示 c-Jun 是 HPSCC 患者可靠的预后因素。